APA (7th ed.) Citation

M, K., W, S., BG, R., YP, Y., J, T., LM, F., . . . JH, L. (2024). Therapeutic targeting at genome mutations of liver cancer by the insertion of HSV1 thymidine kinase through Cas9-mediated editing. Hepatology communications, 8(4), . https://doi.org/10.1097/HC9.0000000000000412

Chicago Style (17th ed.) Citation

M, Kader, Sun W, Ren BG, Yu YP, Tao J, Foley LM, Liu S, Monga SP, and Luo JH. "Therapeutic Targeting at Genome Mutations of Liver Cancer by the Insertion of HSV1 Thymidine Kinase Through Cas9-mediated Editing." Hepatology Communications 8, no. 4 (2024). https://doi.org/10.1097/HC9.0000000000000412.

MLA (9th ed.) Citation

M, Kader, et al. "Therapeutic Targeting at Genome Mutations of Liver Cancer by the Insertion of HSV1 Thymidine Kinase Through Cas9-mediated Editing." Hepatology Communications, vol. 8, no. 4, 2024, https://doi.org/10.1097/HC9.0000000000000412.